Relative Strength Chart StemRIM

Stocks

Delayed Japan Exchange 21:16:58 2026-10-25 EDT			5-day change	1st Jan Change
143.00 ^JPY	-3.38%		-10.06%	-45.63%

10-07	StemRIM Inc. Announces Patent Registration for Stem Cell Gene Therapy Technology SR-GT1 Aimed at Curative Treatment of Dystrophic Epidermolysis Bullosa in USA	CI
09-25	StemRIM Inc. Announces Patent Registration In South Korea For Use Of Redasemtide As Additional Therapeutic Indication Of Cartilage Disorders	CI

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	STEMRIM	Biopharmaceuticals	-3.38%	-10.06%	-45.63%	-50.35%	-73.91%	59.16M